Copper-containing mesoporous bioactive glass scaffolds with multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial activity

Biomaterials

Volumn 34, Issue 2, 2013, Pages 422-433

  Wu, Chengtie ^a   Zhou, Yinghong ^b   Xu, Mengchi ^a   Han, Pingping ^b   Chen, Lei ^a   Chang, Jiang ^a   Xiao, Yin ^b  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Bioactive scaffolds; Bone tissue engineering; Multifunctional properties; Osteostimulation

Indexed keywords

ALKALINE PHOSPHATASE; ANGIOGENESIS; ANTI-BACTERIAL ACTIVITY; ANTIBACTERIAL PROPERTIES; BIOACTIVE SCAFFOLD; BONE DEFECT; BONE TISSUE; BONE TISSUE ENGINEERING; HUMAN BONE MARROW STROMAL CELLS; HYPOXIA-INDUCIBLE FACTORS; LARGE PORES; MESOPORE; MESOPOROUS BIOACTIVE GLASS; MULTIFUNCTIONAL PROPERTIES; MULTIFUNCTIONAL SCAFFOLD; OSTEOCALCIN; OSTEOGENESIS; OSTEOGENIC DIFFERENTIATION; OSTEOPONTIN; OSTEOSTIMULATION; SCAFFOLD SYSTEM; SUSTAINED RELEASE; TISSUE REACTIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BIOACTIVE GLASS; BONE; COPPER; DRUG PRODUCTS; GENE EXPRESSION; PHOSPHATASES; TISSUE;

SCAFFOLDS (BIOLOGY);

ALKALINE PHOSPHATASE; BIOACTIVE GLASS SCAFFOLD; BIOMATERIAL; COPPER; GLASS; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IBUPROFEN; OSTEOCALCIN; OSTEOPONTIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANTIBACTERIAL ACTIVITY; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL VIABILITY; CHEMICAL REACTION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALKALINE PHOSPHATASE; ANGIOGENESIS INDUCING AGENTS; ANTI-BACTERIAL AGENTS; BIOCOMPATIBLE MATERIALS; CELLS, CULTURED; COPPER; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MESENCHYMAL STROMAL CELLS; OSTEOCALCIN; OSTEOGENESIS; OSTEOPONTIN; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

LAKE VICTORIA MARBURGVIRUS;

EID: 84868203482     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.09.066     Document Type: Article

References (54)

1. Hench L.L., Thompson I. Twenty-first century challenges for biomaterials. J R Soc Interface 2010, 7(Suppl. 4):S379-S391.
2. Park J.K., Shim J.H., Kang K.S., Yeom J., Jung H.S., Kim J.Y., et al. Solid free-form fabrication of tissue-engineering scaffolds with a poly(lactic-co-glycolic acid) grafted hyaluronic acid conjugate encapsulating an intact bone morphogenetic protein-2/poly(ethylene glycol) complex. Adv Func Mater 2011, 21(15):2906-2912.
3. Kim T.G., Shin H., Lim D.W. Biomimetic scaffolds for tissue engineering. Adv Funct Mater 2012, 22(12):2446-2468.
4. 2 composite bioceramics. Acta Biomater 2012, 8(1):350-360.
5. Hu Y.C., Zhong J.P. Osteostimulation of bioglass. Chin Med J (Engl) 2009, 122(19):2386-2389.
6. Zhao L.Z., Yan X.X., Zhou X.F., Zhou L., Wang H.N., Tang H.W., et al. Mesoporous bioactive glasses for controlled drug release. Micropor Mesopor Mat 2008, 109(1-3):210-215.
7. Zhu Y., Zhang Y., Wu C., Fang Y., Wang J., Wang S. The effect of zirconium incorporation on the physiochemical and biological properties of mesoporous bioactive glasses scaffolds. Micropor Mesopor Mater 2011, 143:311-319.
8. Yan X., Huang X., Yu C., Deng H., Wang Y., Zhang Z., et al. The in-vitro bioactivity of mesoporous bioactive glasses. Biomaterials 2006, 27(18):3396-3403.
9. Yan X., Yu C., Zhou X., Tang J., Zhao D. Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities. Angew Chem Int Ed Engl 2004, 43(44):5980-5984.
10. Vallet-Regi M.A., Ruiz-Gonzalez L., Izquierdo-Barba I., Gonzalez-Calbet J.M. Revisiting silica based ordered mesoporous materials: medical applications. J Mater Chem 2006, 16(1):26-31.
11. Vallet-Regi M., Balas F., Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed Engl 2007, 46(40):7548-7558.
12. Wu C., Zhou Y., Fan W., Han P., Chang J., Yuen J., et al. Hypoxia-mimicking mesoporous bioactive glass scaffolds with controllable cobalt ion release for bone tissue engineering. Biomaterials 2012, 33(7):2076-2085.
13. Wu C., Miron R., Sculeaan A., Kaskel S., Doert T., Schulze R., et al. Proliferation, differentiation and gene expression of osteoblasts in boron-containing associated with dexamethasone deliver from mesoporous bioactive glass scaffolds. Biomaterials 2011, 32(29):7068-7078.
14. Arcos D., Vallet-Regi M. Sol-gel silica-based biomaterials and bone tissue regeneration. Acta Biomater 2010, 6(8):2874-2888.
15. Li X., Shi J., Dong X., Zhang L., Zeng H. A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior. J Biomed Mater Res A 2008, 84(1):84-91.
16. Wu C., Ramaswamy Y., Zhu Y., Zheng R., Appleyard R., Howard A., et al. The effect of mesoporous bioactive glass on the physiochemical, biological and drug-release properties of poly(dl-lactide-co-glycolide) films. Biomaterials 2009, 30(12):2199-2208.
17. Wu C., Zhang Y., Zhou Y., Fan W., Xiao Y. A comparative study of mesoporous-glass/silk and non-mesoporous-glass/silk scaffolds: physiochemistry and in vivo osteogenesis. Acta Biomater 2011, 7(5):2229-2236.
18. Fan W., Crawford R., Xiao Y. Enhancing in vivo vascularized bone formation by cobalt chloride-treated bone marrow stromal cells in a tissue engineered periosteum model. Biomaterials 2010, 31(13):3580-3589.
19. Fu O.Y., Hou M.F., Yang S.F., Huang S.C., Lee W.Y. Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells. Anticancer Res 2009, 29(8):3131-3138.
20. Basini G., Grasselli F., Bussolati S., Baioni L., Bianchi F., Musci M., et al. Hypoxia stimulates the production of the angiogenesis inhibitor 2-methoxyestradiol by swine granulosa cells. Steroids 2011, 76(13):1433-1436.
21. Oladipupo S., Hu S., Kovalski J., Yao J., Santeford A., Sohn R.E., et al. VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting. Proc Natl Acad Sci USA 2011, 108(32):13264-13269.
22. Semenza G.L. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 2009, 24:97-106.
23. Liu W., Shen S.M., Zhao X.Y., Chen G.Q. Targeted genes and interacting proteins of hypoxia inducible factor-1. Int J Biochem Mol Biol 2012, 3(2):165-178.
24. Ahluwalia A., Tarnawski A.S. Critical role of hypoxia sensor-HIF-1alpha in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr Med Chem 2012, 19(1):90-97.
25. Finney L., Vogt S., Fukai T., Glesne D. Copper and angiogenesis: unravelling a relationship key to cancer progression. Clin Exp Pharmacol Physiol 2009, 36(1):88-94.
26. Gerard C., Bordeleau L.J., Barralet J., Doillon C.J. The stimulation of angiogenesis and collagen deposition by copper. Biomaterials 2010, 31(5):824-831.
27. Hu G.F. Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem 1998, 69(3):326-335.
28. Sen C.K., Khanna S., Venojarvi M., Trikha P., Ellison E.C., Hunt T.K., et al. Copper-induced vascular endothelial growth factor expression and wound healing. Am J Physiol Heart Circ Physiol 2002, 282(5):H1821-H1827.
29. Frangoulis M., Georgiou P., Chrisostomidis C., Perrea D., Dontas I., Kavantzas N., et al. Rat epigastric flap survival and VEGF expression after local copper application. Plast Reconstr Surg 2007, 119(3):837-843.
30. Ewald A., Kappel C., Vorndran E., Moseke C., Gelinsky M., Gbureck U. The effect of Cu(II)-loaded brushite scaffolds on growth and activity of osteoblastic cells. J Biomed Mater Res A 2012, 100(9):2392-2400.
31. Barralet J., Gbureck U., Habibovic P., Vorndran E., Gerard C., Doillon C.J. Angiogenesis in calcium phosphate scaffolds by inorganic copper ion release. Tissue Eng Part A 2009, 15(7):1601-1609.
32. Neel E.A., Ahmed I., Pratten J., Nazhat S.N., Knowles J.C. Characterisation of antibacterial copper releasing degradable phosphate glass fibres. Biomaterials 2005, 26(15):2247-2254.
33. Jaiswal S., McHale P., Duffy B. Preparation and rapid analysis of antibacterial silver, copper and zinc doped sol-gel surfaces. Colloids Surf B Biointerfaces 2012, 94:170-176.
34. Zhu Y., Wu C., Ramaswamy Y., Kockrick E., Simon P., Kaskel S., et al. Preparation, characterization and in vitro bioactivity of mesoporous bioactive glasses (MBGs) scaffolds for bone tissue engineering. Micropor Mesopor Mat 2008, 112(1-3):494-503.
35. Wu C., Fan W., Zhu Y., Gelinsky M., Chang J., Cuniberti G., et al. Magnetic mesoporous bioactive glass scaffolds with hierarchical pore structure and multifunction. Acta Biomater 2011, 7(10):3563-3572.
36. 2 scaffolds with improved mineralization and cytocompatibility for drug delivery and bone tissue engineering. J Mater Chem 2011, 21:18300-18307.
37. ISO/EN 10993-5. Biological evaluation of medical devices-part 5 tests for cytotoxicity, in vitro methods 8.2 tests on extracts.:ISO/EN 10993-5. Biological evaluation of medical devices-part 5 tests for cytotoxicity, in vitro methods 8.2 tests on extracts.
38. Wu C., Ramaswamy Y., Zreiqat H. Porous diopside (CaMgSi(2)O(6)) scaffold: a promising bioactive material for bone tissue engineering. Acta Biomater 2010, 6(6):2237-2245.
39. Chen Q.Z., Thompson I.D., Boccaccini A.R. 45S5 Bioglass-derived glass-ceramic scaffolds for bone tissue engineering. Biomaterials 2006, 27(11):2414-2425.
40. Hutmacher D.W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000, 21(24):2529-2543.
41. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997, 18(1):4-25.
42. Lode A., Wolf-Brandstetter C., Reinstorf A., Bernhardt A., Konig U., Pompe W., et al. Calcium phosphate bone cements, functionalized with VEGF: release kinetics and biological activity. J Biomed Mater Res A 2007, 81(2):474-483.
43. Soker S., Machado M., Atala A. Systems for therapeutic angiogenesis in tissue engineering. World J Urol 2000, 18(1):10-18.
44. Riddle R.C., Khatri R., Schipani E., Clemens T.L. Role of hypoxia-inducible factor-1alpha in angiogenic-osteogenic coupling. J Mol Med (Berl) 2009, 87(6):583-590.
45. Weidemann A., Johnson R.S. Biology of HIF-1alpha. Cell Death Differ 2008, 15(4):621-627.
46. Hu X., Yu S.P., Fraser J.L., Lu Z., Ogle M.E., Wang J.A., et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 2008, 135(4):799-808.
47. Hench L.L., Polak J.M. Third-generation biomedical materials. Science 2002, 295(5557):1014-1017.
48. Kim H.W., Kim H.E., Knowles J.C. Production and potential of bioactive glass nanofibers as a next-generation biomaterial. Adv Funct Mater 2006, 16(12):1529-1535.
49. Rodriguez J.P., Rios S., Gonzalez M. Modulation of the proliferation and differentiation of human mesenchymal stem cells by copper. J Cell Biochem 2002, 85(1):92-100.
50. Hong Y.L., Chen X.S., Jing X.B., Fan H.S., Gu Z.W., Zhang X.D. Fabrication and drug delivery of ultrathin mesoporous bioactive glass hollow fibers. Adv Funct Mater 2010, 20(9):1501-1510.
51. Wu C., Fan W., Gelinsky M., Xiao Y., Simon P., Schulze R., et al. Bioactive SrO-SiO(2) glass with well-ordered mesopores: characterization, physiochemistry and biological properties. Acta Biomater 2011, 7(4):1797-1806.
52. Zhang C., Li C., Huang S., Hou Z., Cheng Z., Yang P., et al. Self-activated luminescent and mesoporous strontium hydroxyapatite nanorods for drug delivery. Biomaterials 2010, 31(12):3374-3383.
53. Zhu Y.F., Kaskel S. Comparison of the in vitro bioactivity and drug release property of mesoporous bioactive glasses (MBGs) and bioactive glasses (BGs) scaffolds. Micropor Mesopor Mater 2009, 118(1-3):176-182.
54. Grass G., Rensing C., Solioz M. Metallic copper as an antimicrobial surface. Appl Environ Microbiol 2011, 77(5):1541-1547.